Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

  1. Lookup NU author(s)
  2. Professor Graham Jackson
Author(s)Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Coy NN, Cook G, Feyler S, Johnson PRE, Rudin C, Drayson MT, Owen RG, Ross FM, Russell NH, Jackson GH, Child JA, NCRI Haematological Oncology
Publication type Article
JournalHaematologica
Year2012
Volume97
Issue3
Pages442-450
ISSN (print)0390-6078
ISSN (electronic)1592-8721
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherFondazione Ferrata Storti
URLhttp://dx.doi.org/10.3324/haematol.2011.043372
DOI10.3324/haematol.2011.043372
Actions    Link to this publication